The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the treatment of multiple myeloma (MM), the second most common type of blood ...

The first patient blood samples, just weeks away, will open a new chapter in medicine’s ongoing search for a therapy that ...

CTCs are rare cancer cells that tumors shed in the blood. They've been looked at before in prostate cancer, but only in its ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

For some patients with breast cancer, ctDNA may have the potential to predict disease relapse after they have undergone ...

T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach ...

A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer ...

UC San Diego School of Medicine researchers discover a groundbreaking oral breast cancer drug that is also effective in ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

Social media personality Rachel Yaffe died on Friday, October 11, after battling a rare form of liver cancer. She was 27.